Evidence map›Paper›PMID 33195266›Full record

ArticleFrontiers in cell and developmental biology2020

Employing Flow Cytometry to Extracellular Vesicles Sample Microvolume Analysis and Quality Control.

Joana Maia, Silvia Batista, Nuno Couto, Ana C Gregório, Cristian Bodo, Julia Elzanowska, Maria Carolina Strano Moraes, Bruno Costa-Silva

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Extracellular vesicles: key mediators inFrontiers in veterinary science · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Double Digital Assay for Single Extracellular Vesicle and Single Molecule Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. IgGCells · 2022
    Article
  19. Article
  20. Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joana MaiaChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Silvia BatistaChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Nuno CoutoChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Ana C GregórioChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Cristian BodoChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Julia ElzanowskaChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Maria Carolina Strano MoraesChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Bruno Costa-SilvaChampalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular Vesicles (EVs), membrane vesicles released by all cells, are emerging mediators of cell-cell communication. By carrying biomolecules from tissues to biofluids, EVs have attracted attention as non-invasive sources of clinical biomarkers in liquid biopsies. EVs-based liquid biopsies usually require EVs isolation before content analysis, which frequently increases sample volume requirements. We here present a Flow Cytometry (FC) strategy that does not require isolation or concentration of EVs prior to staining. By doing so, it enables population analysis of EVs in samples characterized by challenging small volumes, while reducing overall sample processing time. To illustrate its application, we performed longitudinal non-lethal population analysis of EVs in mouse plasma and in single-animal collections of murine vitreous humor. By quantifying the proportion of vesicular particles in purified and non-purified biological samples, this method also serves as a precious tool to quality control isolates of EVs purified by different protocols. Our FC strategy has an unexplored clinical potential to analyze EVs in biofluids with intrinsically limited volumes and to multiply the number of different analytes in EVs that can be studied from a single collection of biofluid.

Indexed as

cancer flow cytometryexosomesextracellular vesiclesliquid biopsylongitudinal studymicrovolumepopulation studysample purity

Identifiers

PMID33195266
PMCPMC7661467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.